Covetrus and MWI plan merger to build larger vet platform
Covetrus and MWI Animal Health have agreed to merge in a deal that would create a larger animal health platform spanning distribution, pharmacy, software, and practice services across companion, equine, and production animal markets. The transaction values MWI at $3.5 billion. Under the agreement announced February 18, 2026, MWI parent Cencora would receive $1.25 billion in cash, $800 million in perpetual preferred equity, and $1.45 billion in common equity, leaving Cencora with a 34.3% non-controlling stake in the combined company. The companies said the merger is intended to pair MWI’s supply chain and distribution reach with Covetrus’ technology and practice-management tools. The deal is still subject to customary closing conditions, including regulatory approvals, and Cencora has said it doesn’t expect the transaction to close before September 30, 2026. (investor.cencora.com)
Why it matters: For veterinary professionals, this is another sign that the supplier and practice-technology landscape is continuing to consolidate. If the deal closes, clinics could see a broader single-vendor offering that links product distribution with software, pharmacy, and operational services. That could simplify purchasing and workflow for some practices, but it also raises familiar questions about pricing leverage, vendor choice, integration, and how much influence one platform may have across the day-to-day business side of care. Covetrus itself has been private since its 2022 acquisition by Clayton, Dubilier & Rice and TPG, and the new structure would keep Cencora financially tied to the business even as it shifts focus toward its human-health core. Reuters also reported that one Wall Street analyst viewed the move as a logical way for Cencora to narrow its strategic focus. (covetrus.com)
What to watch: Watch for antitrust review, any customer-facing integration plans, and whether the companies spell out how ordering, software, pharmacy, and account relationships would change before a closing that currently isn’t expected before September 30, 2026. (stocktitan.net)